147 related articles for article (PubMed ID: 1706513)
41. A retrospective analysis of 111 canine prostatic samples: histopathological findings and classification.
Palmieri C; Lean FZ; Akter SH; Romussi S; Grieco V
Res Vet Sci; 2014 Dec; 97(3):568-73. PubMed ID: 25468798
[TBL] [Abstract][Full Text] [Related]
42. Heat shock protein 90 is associated with hyperplasia and neoplastic transformation of canine prostatic epithelial cells.
Palmieri C; Mancini M; Benazzi C; Della Salda L
J Comp Pathol; 2014 May; 150(4):393-8. PubMed ID: 24679854
[TBL] [Abstract][Full Text] [Related]
43. Flow cytometry of prostate cancer: relationship of DNA content to survival.
Stephenson RA; James BC; Gay H; Fair WR; Whitmore WF; Melamed MR
Cancer Res; 1987 May; 47(9):2504-7. PubMed ID: 3567934
[TBL] [Abstract][Full Text] [Related]
44. Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancer.
Nordgren H; Nilsson S; Eklöv S; Stattin P; Naining W; Heiden T; Bergkvist L; Karlberg L; Lundholm C; Harvig B
Acta Oncol; 1991; 30(2):211-4. PubMed ID: 2029408
[TBL] [Abstract][Full Text] [Related]
45. Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions.
Mirtti T; Kallajoki M; Aaltonen M; Alanen K
Anal Quant Cytol Histol; 2001 Jun; 23(3):229-37. PubMed ID: 11444193
[TBL] [Abstract][Full Text] [Related]
46. Deoxyribonucleic acid flow cytometry of benign prostatic disease.
Deitch AD; Strand MA; de Vere White RW
J Urol; 1989 Sep; 142(3):759-62. PubMed ID: 2769856
[TBL] [Abstract][Full Text] [Related]
47. Role of adhesion molecules and proliferation hyperplasic, pre neoplastic and neoplastic lesions in canine prostate.
Rodrigues MM; Rema A; Gartner MF; Laufer-Amorim R
Pak J Biol Sci; 2013 Nov; 16(21):1324-9. PubMed ID: 24511741
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
[TBL] [Abstract][Full Text] [Related]
49. Androgen receptor expression and DNA content of paraffin-embedded archival human prostate tumors.
Adiga SK; Andritsch I; Rao RV; Krishan A
Cytometry; 2002 Feb; 50(1):25-30. PubMed ID: 11857595
[TBL] [Abstract][Full Text] [Related]
50. [Flow cytometric DNA analysis in rectal carcinomas].
Araki Y
Nihon Geka Gakkai Zasshi; 1989 Dec; 90(12):1965-75. PubMed ID: 2626151
[TBL] [Abstract][Full Text] [Related]
51. DNA flow cytometric study of thymic epithelial tumors with evaluation of its usefulness in the pathologic classification.
Kuo TT; Lo SK
Hum Pathol; 1993 Jul; 24(7):746-9. PubMed ID: 8319953
[TBL] [Abstract][Full Text] [Related]
52. Predictability of PSA failure in prostate cancer by computerized cytometric assessment of tumoral cell proliferation.
Diaz JI; Mora LB; Austin PF; Muro-Cacho CA; Cantor AB; Nicosia SV; Pow-Sang JM
Urology; 1999 May; 53(5):931-8. PubMed ID: 10223486
[TBL] [Abstract][Full Text] [Related]
53. Expression of β-catenin and mesenchymal markers in canine prostatic hyperplasia and carcinoma.
Lean FZ; Kontos S; Palmieri C
J Comp Pathol; 2014 May; 150(4):373-81. PubMed ID: 24529514
[TBL] [Abstract][Full Text] [Related]
54. [Comparison between nuclear DNA and histologic grade of prostatic carcinoma].
Zattoni F; Prayer Galetti T; Vianello F; Bertoldin R; Panozzo M; Blandamura S; Costantin G
J Urol (Paris); 1992; 98(4):192-5. PubMed ID: 1284300
[TBL] [Abstract][Full Text] [Related]
55. Flow cytometric and clinicopathologic study of 197 hydatidiform moles with special reference to the significance of cytometric aneuploidy and literature review.
Fukunaga M; Endo Y; Ushigome S
Cytometry; 1995 Jun; 22(2):135-8. PubMed ID: 7587744
[TBL] [Abstract][Full Text] [Related]
56. Nuclear DNA analysis of prostate tissues: correlation with stage and grade of tumour.
Neill WA; Norval M; Habib FK
Urol Int; 1989; 44(3):141-6. PubMed ID: 2473565
[TBL] [Abstract][Full Text] [Related]
57. Image analysis confirmation of DNA aneuploidy in flow cytometric DNA distributions having a wide coefficient of variation of the G0/G1 peak.
McFadden PW; Clowry LJ; Daehnert K; Hause LL; Koethe SM
Am J Clin Pathol; 1990 May; 93(5):637-42. PubMed ID: 2327365
[TBL] [Abstract][Full Text] [Related]
58. Flow cytometric nuclear DNA content of fresh and paraffin-embedded tissues of breast carcinomas and fibroadenomas.
De Vita R; Calugi A; Eleuteri P; Maggi O; Nassuato C; Vecchione A
Eur J Basic Appl Histochem; 1991; 35(3):233-44. PubMed ID: 1718443
[TBL] [Abstract][Full Text] [Related]
59. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
[TBL] [Abstract][Full Text] [Related]
60. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
